Vitrolife: Allotment of Acquisition Cost Decided by the Swedish Tax Agency

Published: Dec 20, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

In connection with Vitrolife’s (STO:VITR) distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.

Back to news